Drug
Liposomal Cytarabine clinical trials
A product of Cytarabine; its studies count on that page too.
- studies test it
- 19
- open now
- 0
- in phase 3
- 5
- first study started
- 1996
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1997 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 11
- Phase 3
- 5
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 18
Goethe University (2) · PETHEMA Foundation (2) · International Extranodal Lymphoma Study Group (IELSG) (1) · Andrés José Maria Ferreri (1) · Nordic Lymphoma Group (1) · Centre Oscar Lambret (1) · University of Washington (1) · Northern Italy Leukemia Group (1)
Often tested with
Tested in the same studies.
Methotrexate (4) · Cyclophosphamide (3) · Vincristine (3) · Rituximab (2) · Prednisolone (2) · Dexamethasone (2) · Mercaptopurine (2) · Asparaginase (2)
Studies
Open first, then newest update. How each study uses Liposomal Cytarabine is read from its arms, and is right about nine times in ten.
Testing it · 19
- Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of TestisCompletedPhase 2International Extranodal Lymphoma Study Group (IELSG)NCT00945724Written as Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone, liposomal cytarabine, methotrexate
- High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System InvolvementCompletedPhase 2Andrés José Maria FerreriNCT00801216Written as High-dose sequential chemotherapy and autologous transplant
- Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenStatus unknownPhase 2National Cancer Institute, NaplesNCT01593488Written as liposomal cytarabine
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 4Goethe UniversityNCT00198978Written as Depocyte
- Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With DepocytCompletedPhase 2/3Goethe UniversityNCT00199108Written as Depocyt
- Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic LymphomaTerminatedPhase 2University of California, San DiegoNCT02043587Written as Liposomal AraC
- CHemoImmunotherapy With Early Central Nervous System (CNS) ProphylaxisCompletedPhase 2Nordic Lymphoma GroupNCT01325194Written as liposomal cytarabine
- Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast CancerCompletedPhase 3Centre Oscar LambretNCT01645839Written as Liposomal Cytarabine
- Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerCompletedPhase 2University of WashingtonNCT00992602Written as liposomal cytarabine
- A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the BrainTerminatedPhase 1University Hospital, BonnNCT01563614Written as Liposomal cytarabine
- PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic LeukemiaTerminatedPhase 3PETHEMA FoundationNCT00944008Written as DepoCyte
- Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic LeukemiaCompletedPhase 2/3Northern Italy Leukemia GroupNCT00795756Written as liposome-encapsulated cytarabine (DepoCyte)
- Depocyt® With Sorafenib in Neoplastic MeningitisTerminatedNot applicableH. Lee Moffitt Cancer Center and Research InstituteNCT00964743Written as DepoCyt
- DepoCyt for Active Lymphomatous or Leukemic MeningitisTerminatedPhase 2Duke UniversityNCT00523939Written as cytarabine liposome injection
- Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedPhase 2National Cancer Institute (NCI)NCT00002704Written as liposomal cytarabine
- Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)SuspendedPhase 3Nordic Society for Pediatric Hematology and OncologyNCT00991744Written as Liposomal cytarabine
- DepoCyt Plus Temozolomide in Patients With Neoplastic MeningitisTerminatedPhase 1M.D. Anderson Cancer CenterNCT00515788Written as DepoCyt
- Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive LymphomaCompletedPhase 2PETHEMA FoundationNCT00388531Written as Depocyte®
- Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid TumorsStatus unknownPhase 1Pacira Pharmaceuticals, IncNCT00003073Written as liposomal cytarabine
Given in every arm · 3 — Liposomal Cytarabine is usual care beside what is tested
- Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLRecruitingPhase 2New York Medical CollegeNCT02393157Written as Liposomal ARA-C
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaCompletedPhase 2AIDS Malignancy ConsortiumNCT00392834Written as liposomal cytarabine
- Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedPhase 2Beth Israel Deaconess Medical CenterNCT00073957Written as liposomal cytarabine